Our previous reports regarding autoactivation and impaired function of the Jak-Stat pathway [37], [45] and our data in this study-all may suggest that the Jak-Stat signaling pathway may be an excellent target for immunotherapy of T1D and may also be effective in type II diabetes, although this remains to be seen [51]. The gene discussed is SOAT1; the disease is type 1 diabetes mellitus.